0000876661-23-000590.txt : 20230719
0000876661-23-000590.hdr.sgml : 20230719
20230719110715
ACCESSION NUMBER: 0000876661-23-000590
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
EFFECTIVENESS DATE: 20230719
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: SQZ Biotechnologies Co
CENTRAL INDEX KEY: 0001604477
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462431115
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39662
FILM NUMBER: 231095990
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., STE. 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-898-8824
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., STE. 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
0001604477
SQZ Biotechnologies Co
001-39662
200 Arsenal Yards Boulevard, Suite 210
Watertown
MA
MASSACHUSETTS
02472
+1 (617) 758-8672
Common Stock
17 CFR 240.12d2-2(b)
Daniel Contrastano
Manager, Market Watch & Proxy Compliance
2023-07-19
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange ("NYSE" or the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove the entire class of common stock (the "Securities") of SQZ Biotechnologies Company (the "Company") from listing and registration on the Exchange on July 31, 2023, pursuant to the provisions of Rule 12d2-2(b) because, in the opinion of the Exchange, the Securities are no longer suitable for continued listing and trading on the NYSE.
The Exchange has determined to delist the Company's Securities pursuant to Section 802.01B of the NYSE's Listed Company Manual because the Company had fallen below the NYSE's continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000.
On July 3, 2023, the Exchange determined that the Securities of the Company should be suspended from trading and directed the preparation and filing with the Commission of this application for the removal of the Securities from listing and registration on the NYSE. The Company was notified on July 3, 2023.
Pursuant to the above authorization, a press release regarding the proposed delisting was issued and posted on the Exchange's website on July 3, 2023, and trading in the Securities was immediately suspended.
The Company had a right to appeal to a Committee of the Board of Directors of the Exchange, the determination to delist the Securities, provided it filed a written request for such a review with the Secretary of the Exchange within ten business days of receiving notice of the delisting determination. The Company did not file such request within the specified period. Consequently, all conditions precedent under SEC Rule 12d2-2(b) to the filing of this application have been satisfied.